Anthropic has opened the investor roadshow for its initial public offering, setting a price range of $70 to $78 a share for 825 million Class A shares. At the top of that range, the deal would raise $64.35bn before fees, making it one of the largest technology listings in years.

The company plans to list on the Nasdaq Global Select Market under the ticker ANT. People familiar with the process told CNBC that pricing is expected on 18 November, with trading starting on 19 November, before Thanksgiving. Anthropic itself has not confirmed the trading date.

For anyone who uses Claude, invests in tech stocks or simply wants to understand how the AI boom is being valued, this is the moment the numbers become real. A private valuation is an opinion. A public share price is a test.

What exactly is Anthropic selling?

An IPO is the first time a private company sells shares to the public. In this case, the offering is 825 million Class A shares. Anthropic is selling 801,351,354 of them; existing shareholders are selling the other 23,648,646. Anthropic will not receive any of the proceeds from the shares sold by those holders.

The company has also given the underwriters a 30-day option to buy up to 123.75 million more shares. If that option is used in full, the offering grows to 948.75 million shares. Goldman Sachs and Morgan Stanley are leading the deal.

The shares are expected to price between $70 and $78. Multiply that by 825 million and you get gross proceeds of $57.75bn to $64.35bn. The final number depends on where the book lands and how many shares the underwriters take.

How much would Anthropic be worth?

Valuation is the price of one share multiplied by the number of shares. That sounds simple until you decide which share count to use.

On the roughly 13 billion shares implied by the filing, $78 a share gives a valuation of about $1.02tn. On a fully diluted basis, which counts options, restricted stock and other claims that could turn into shares, CNBC puts the top-end valuation at about $1.405tn. Both numbers can be correct. They answer different questions.

The fully diluted figure is the one to watch if you care about what public investors are really paying for the whole company. The simpler figure is the one that will appear in headlines.

For context, Anthropic was valued at $965bn in a private funding round in May. Reuters reported that investors had discussed a valuation of as much as $2tn earlier in the process, before the company’s infrastructure commitments and a wobble in AI stocks brought expectations down. The final range is a compromise between what the company wanted and what buyers were willing to underwrite.

The revenue picture is what makes the valuation arguable. An amended S-1/A reportedly showed $16.96bn in third-quarter revenue. Annualised, that is about $68bn. Against the $1.02tn figure, the shares are trading at roughly 15 times sales. Against the fully diluted $1.405tn, they are closer to 21 times.

For a company growing at triple-digit rates, 15 times sales is aggressive but not absurd. At 21 times, there is less room for a growth scare. And Anthropic is not a typical software company: it rents enormous amounts of compute, pays for the chips and data centres that train its models, and reinvests most of its gross profit into the next generation. The S-1’s gross margin and customer concentration will matter more than the headline price range.

The $26bn side deal

One detail deserves more attention than it got in the first headlines. Anthropic has agreements with AMD, Broadcom, Google, Micron, Microsoft, Nvidia and TSMC to buy $26bn of its Class N common stock in a private placement at the IPO price.

That is strategic money from the companies that supply or host its compute. It also means the public offering is not the only source of capital. The private-placement shares are not part of the public offering and are not covered by the underwriters’ lock-up, so they could add supply on a different timetable.

When will Anthropic stock start trading?

CNBC, citing people familiar with the deal, reports that Anthropic plans to price the IPO on 18 November and begin trading on Nasdaq on 19 November. The company has not confirmed those dates, and IPO schedules can slip.

Anthropic is also targeting a retail allocation of about 20%, according to CNBC, well above the 5% to 10% typical for a large IPO. That means individual investors may get a larger slice than usual. It does not mean everyone who wants shares will get them. Allocation depends on the broker, demand and the size of the order.

If you want to own the stock, you do not need an IPO allocation. You can wait for it to trade under ANT and buy it like any other Nasdaq stock. The trade-off is that first-day prices can move sharply, and the opening print is often far from the IPO price. None of this is a recommendation to buy the stock.

What could go wrong?

Plenty. The AI trade has been volatile, and Anthropic’s costs are rising as fast as its revenue. A public company also has to report every quarter, explain its margins and defend its spending to shareholders who may not share its safety-first culture.

The mechanics add their own risk. A small float, roughly 6% of the shares on the simpler count, can amplify first-day moves in both directions. The lock-up will eventually let early investors and employees sell, adding supply. The $26bn private placement adds another group of holders with their own timetable.

Then there is the market itself. A strong debut would give other AI labs a public benchmark and make it easier for OpenAI and others to raise money. A weak one would change the conversation about how much capital the sector can absorb. Either outcome is possible, and a hot first day is not proof that the business will justify its price five years from now.

What does the IPO mean for Claude users?

In the short term, very little. Your Claude plan does not change because the company listed. In the longer term, a public Anthropic answers to public shareholders. That can bring more transparency about pricing, usage and roadmaps. It can also create pressure to raise prices, cut costs or chase revenue in ways a private company might resist.

Anthropic has built its brand around safety and long-term thinking. Public markets are quarterly by design. How the company balances those two things will be one of the most closely watched experiments in the AI industry.

The bottom line

Anthropic’s IPO is one of the first real public-market tests of what a frontier AI lab is worth. The price range values the company at roughly $1tn on the simple share count, or about $1.4tn fully diluted. The deal could raise up to $64.35bn, with a $26bn private placement alongside it.

Watch three things: the final price on 18 November, the first trade on 19 November and the size of the retail allocation. Those numbers will tell you more about demand than any roadshow quote. For everyone else, the lesson is simpler: the AI boom now has a ticker, and the market is about to put a daily price on it.

Have a tip? Email [email protected] or use the contact form and choose Editorial. We do not promise anonymity.

Source: Anthropic; CNBC.